GHDX Shares Outstanding History



Below is a table of the GHDX shares outstanding history going back to 2/26/2010:

Date GHDX Shares Outstanding
2/26/201028.73M
4/30/201028.78M
7/30/201028.82M
10/29/201028.86M
2/28/201129.12M
4/29/201129.27M
7/29/201129.49M
10/31/201129.54M
2/29/201229.99M
4/30/201230.05M
7/31/201230.44M
2/28/201330.12M
4/30/201330.22M
7/31/201330.62M
10/31/201330.74M
2/28/201431.18M
4/30/201431.24M
7/31/201431.53M
10/31/201431.72M
2/28/201532.17M
4/30/201532.26M
7/31/201532.48M
10/31/201532.54M
2/29/201632.98M
4/30/201633.02M
7/31/201633.35M
10/31/201633.48M
2/28/201734.07M
4/30/201734.34M
7/31/201734.65M
10/31/201734.79M
2/28/201835.32M
4/30/201835.38M
7/31/201835.86M
10/31/201836.12M
2/22/201936.90M
4/30/201937.07M
7/31/201937.29M
10/28/201937.59M

Also see: GHDX Market Cap History
GHDX YTD Return
GHDX Historical Shares Outstanding:
+2.82% CAGR
GHDX Historical Shares Outstanding: +2.82% CAGR

Mouse over chart for data details
2/26/2010 ...10/28/2019
Genomic Health provides genomic information to personalize cancer treatment decisions. Co. develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make treatment decisions. Co. provides its tissue-based invasive breast, ductal carcinoma in situ (DCIS), prostate and colon Oncotype DX tests as clinical laboratory services, where it analyzes the expression levels of genes in tumor tissue samples and provides physicians with a gene expression profile expressed as a single quantitative score. Co. also provides an Oncotype DX test for patients with DCIS, a pre-invasive form of breast cancer. We show 39 historical shares outstanding datapoints in our coverage of GHDX's shares outstanding history.

Understanding the changing numbers of GHDX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GHDX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GHDX by allowing them to research GHDX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree GHDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Genomic Health (GHDX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

GILD Shares Outstanding History
GKOS Shares Outstanding History
GLSI Shares Outstanding History
GLTO Shares Outstanding History
GLUE Shares Outstanding History
GLYC Shares Outstanding History
GMED Shares Outstanding History
GMTX Shares Outstanding History
GNCA Shares Outstanding History
GNLX Shares Outstanding History
More Healthcare companies »

 

GHDX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.